Search

everythinglearnresearchcommunity

for

Search:↓

New genes and pathways are important for testosterone production and male sexual development.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Finger length ratio may indicate male hair loss.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.